Maria de Lourdes Setsuko Ayrizono
Overview
Explore the profile of Maria de Lourdes Setsuko Ayrizono including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodrigues B, Pascoal L, Genaro L, Warrak L, Rodrigues B, Coope A, et al.
Cells
. 2025 Feb;
14(4).
PMID: 39996742
Background: Crohn's disease (CD) is an inflammatory bowel disease marked by an abnormal immune response and excessive pro-inflammatory cytokines, leading to impaired protein processing and endoplasmic reticulum (ER) stress. This...
2.
Genaro L, Carron J, de Castro M, Franceschini A, Lourenco G, Cruz C, et al.
Int J Immunopathol Pharmacol
. 2025 Feb;
39:3946320251319379.
PMID: 39959979
Crohn's disease (CD) involves immune system interactions with intestinal tissue, driven by pro-inflammatory cytokines like Tumor Necrosis Factor (TNF-α). Adalimumab, targeting TNF-α, regulates associated inflammatory responses. Despite being humanized, it...
3.
Ceccato H, Silva T, Genaro L, Silva J, de Souza W, Oliveira P, et al.
Am J Transl Res
. 2025 Feb;
17(1):28-46.
PMID: 39959235
Introduction: Inflammatory Bowel Disease (IBD), encompassing Crohn's disease and ulcerative colitis, presents significant clinical challenges due to its heterogeneous nature and complex etiology. Recent advancements in biomedical research have enhanced...
4.
Christiano A, Bonilha D, Marchiori Junior M, Oliveira P, Ayrizono M
Arq Bras Cir Dig
. 2025 Feb;
37:e1864.
PMID: 39936819
Background: The carcinogenesis of colorectal cancer is well understood. Adenomas are the precursor lesions in about 70% of cases, highlighting the importance of screening programs. Aims: The aim of this...
5.
Gomes L, Genaro L, de Castro M, Ricci R, Pascoal L, Silva F, et al.
Therap Adv Gastroenterol
. 2024 Dec;
17:17562848241251949.
PMID: 39664232
Background: The treatment for Crohn's disease (CD) has increasingly required the use of biological agents. Safe and affordable tests have led to the active implementation of therapeutic drug monitoring (TDM)...
6.
Bonfitto P, Rodrigues B, Siqueira N, Genaro L, Rodrigues B, Oliveira P, et al.
Am J Cancer Res
. 2024 Dec;
14(11):5133-5153.
PMID: 39659922
Colorectal cancer (CRC) is one of the most widespread tumor types, and it stands as the second leading cause of disease-related mortality globally. Due to its adverse effects, which lead...
7.
Silva J, de Souza W, Mello J, Ceccato H, Oliveira P, Ayrizono M, et al.
Am J Transl Res
. 2024 Nov;
16(10):6029-6040.
PMID: 39544780
Objective: To conduct a systematic review (SR) to find evidence for a connection between Crohn's disease (CD) and the gut-brain axis (GBA). Methods: This study conducted a systematic review (SR)...
8.
Filho A, Pazin G, Genaro L, Oliveira P, Ayrizono M, Leal R
Int J Surg Case Rep
. 2024 Sep;
123:110271.
PMID: 39260341
Introduction: Hidradenitis Suppurativa (HS) is a chronic inflammatory disorder that affects the pilosebaceous unit. Squamous Cell Carcinoma (SCC) can emerge as a complication. Presentation Of Case: A 58-year-old male patient...
9.
Steigleder K, Pascoal L, Siqueira N, Simino L, Ayrizono M, Milanski Ferreira M, et al.
Gastro Hep Adv
. 2024 Aug;
3(1):17-30.
PMID: 39132178
Background And Aims: Recent evidence suggests that the mesenteric adipose tissue (MAT) near the affected intestine may play a role in Crohn's disease (CD) pathophysiology. Modulation of several transcripts has...
10.
Credidio L, Martinez C, Magro D, Carvalho R, Ayrizono M, Coy C
Arq Gastroenterol
. 2024 Mar;
61:e23131.
PMID: 38451667
Background: To evaluate the relationship between the ratio of affected lymph nodes (LNR) and clinical and anatomopathological variables in patients with rectal adenocarcinoma submitted or not to neoadjuvant chemoradiotherapy. Methods:...